146 related articles for article (PubMed ID: 6096150)
1. Immunological observations before and after successful treatment of chronic mucocutaneous candidiasis with ketoconazole and transfer factor.
Corbeel L; Ceuppens JL; Van den Berghe G; Claeys H; Casteels-Van Daele M
Eur J Pediatr; 1984 Nov; 143(1):45-8. PubMed ID: 6096150
[TBL] [Abstract][Full Text] [Related]
2. Transfer factor in chronic mucocutaneous candidiasis.
Masi M; De Vinci C; Baricordi OR
Biotherapy; 1996; 9(1-3):97-103. PubMed ID: 8993766
[TBL] [Abstract][Full Text] [Related]
3. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect].
Rytter M; Schönborn C; Lohrisch I; Haustein UF
Z Gesamte Inn Med; 1986 Apr; 41(7):214-6. PubMed ID: 3521108
[TBL] [Abstract][Full Text] [Related]
4. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
Mobacken H; Lindholm L; Moberg S
Acta Derm Venereol; 1987; 67(3):257-60. PubMed ID: 2442942
[TBL] [Abstract][Full Text] [Related]
5. Chronic mucocutaneous candidiasis with IgA deficiency in a two-year-old African girl who responded well to ketoconazole.
Coovadia HM; Hamed Z; Bayles MA; Kiepiela P
Ann Trop Paediatr; 1983 Sep; 3(3):111-4. PubMed ID: 6197018
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole in a case of chronic mucocutaneous candidiasis.
Zachariae H; Laurberg G; Thestrup-Pedersen K
Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
[TBL] [Abstract][Full Text] [Related]
7. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
[TBL] [Abstract][Full Text] [Related]
8. Transfer factor (TFd). Part IV. Transfer factor in mucocutaneous candidiasis treatment.
Miksiewicz-Wasilewska H; Grubek-Jaworska A; Plucińska M; Podsiadło B; Krakówka P; Rzucidło L
Mater Med Pol; 1981; 13(2):108-12. PubMed ID: 7345253
[No Abstract] [Full Text] [Related]
9. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
Barnaba V; Zaccari C; Levrero M; Balsano F
Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
[TBL] [Abstract][Full Text] [Related]
10. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
Rocklin RE
Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis of Candida albicans in chronic mucocutaneous candidiasis.
Bortolussi R; Faulkner G; Lee SH; Ozere R
Pediatr Res; 1981 Sep; 15(9):1287-92. PubMed ID: 7027155
[TBL] [Abstract][Full Text] [Related]
12. Host factors in defense against fungal infections.
Kirkpatrick CH
Am J Med; 1984 Oct; 77(4D):1-12. PubMed ID: 6388323
[TBL] [Abstract][Full Text] [Related]
13. Restoration of cell-mediated immune responses with transfer factor.
Kirkpatrick CH
Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
[TBL] [Abstract][Full Text] [Related]
14. Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole.
Williamson MM; Gordon RD
Med J Aust; 1983 Mar; 1(6):276-8. PubMed ID: 6298584
[TBL] [Abstract][Full Text] [Related]
15. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans.
Burford-Mason AP; Matthews RC; Williams JR
J Infect; 1987 Mar; 14(2):147-57. PubMed ID: 2952735
[TBL] [Abstract][Full Text] [Related]
16. [Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
Pérez Suárez de Durandeau L; Salinas Carmona MC; Silva Siwady JG; Hinojosa Ayala JR
Med Cutan Ibero Lat Am; 1986; 14(5):357-63. PubMed ID: 3543557
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune-enhancing effects of ibuprofen in an immunodeficiency model.
Jorizzo JL; Goldblum RM; Daniels JC; Ichikawa Y; Langford MP; Fagan KM
Int J Dermatol; 1985 Apr; 24(3):183-7. PubMed ID: 3922905
[TBL] [Abstract][Full Text] [Related]
18. [Phagocytic activity of the neutrophilic granulocytes of patients with chronic generalized (granulomatous) candidiasis].
Stepanova ZhV; Kurshakova TS
Vestn Dermatol Venerol; 1986; (1):61-4. PubMed ID: 3962491
[No Abstract] [Full Text] [Related]
19. Chronic mucocutaneous candidiasis.
Kirkpatrick CH
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):448-56. PubMed ID: 2502409
[TBL] [Abstract][Full Text] [Related]
20. Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
Mobacken H; Moberg S
Dermatologica; 1986; 173(5):229-36. PubMed ID: 3100354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
